LY2183240
CAS No. 874902-19-9
LY2183240( —— )
Catalog No. M24889 CAS No. 874902-19-9
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 36 | In Stock |
|
| 25MG | 74 | In Stock |
|
| 50MG | 141 | In Stock |
|
| 100MG | 221 | In Stock |
|
| 200MG | 325 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2183240
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
-
DescriptionLY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
-
In Vitro——
-
In VivoLY2183240 (3-30mg/kg; i.p.) dose-dependently attenuates formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms. Animal Model:Male Sprague-Dawley rats (Formalin Pain Model)Dosage:3, 10, 30 mg/kg Administration:I.p.Result:Dose-dependently attenuated formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms.
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy|FAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874902-19-9
-
Formula Weight307.35
-
Molecular FormulaC17H17N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (162.68 mM; Need ultrasonic)
-
SMILESO=C(N(C)C)N1N=NN=C1CC(C=C2)=CC=C2C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dickason-Chesterfield AK, et al. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23.
molnova catalog
related products
-
Talarozole
Talarozole is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM respectively.Talarozole for the treatment of acne psoriasis and other keratinization disorders.
-
DCC-3116
DCC-3116 is an orally active, selective and potent ULK1/2 inhibitor with anticancer activity.DCC-3116 inhibits autophagy and can be used in cancer research.
-
CA-5f
CA-5f is a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion.
Cart
sales@molnova.com